BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2405109)

  • 1. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy.
    Guthrie TH; Porubsky ES; Luxenberg MN; Shah KJ; Wurtz KL; Watson PR
    J Clin Oncol; 1990 Feb; 8(2):342-6. PubMed ID: 2405109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin.
    Guthrie TH; McElveen LJ; Porubsky ES; Harmon JD
    Cancer; 1985 Apr; 55(8):1629-32. PubMed ID: 4038911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face.
    Merimsky O; Neudorfer M; Spitzer E; Chaitchik S
    Anticancer Drugs; 1992 Oct; 3(5):481-4. PubMed ID: 1450442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cisplatin-based chemotherapy for advanced basal and squamous cell carcinomas].
    Goldberg H; Tsalik M; Bernstein Z; Haim N
    Harefuah; 1994 Oct; 127(7-8):217-21, 286. PubMed ID: 7813942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous-cell cancer of the head and neck.
    Dasmahapatra KS; Citrin P; Hill GJ; Yee R; Mohit-Tabatabai MA; Rush BF
    J Clin Oncol; 1985 Nov; 3(11):1486-9. PubMed ID: 4056841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekly Multi-agent Chemotherapy (CMF-b) for Advanced Non-melanoma Skin Cancer.
    Espeli V; Ruegg E; Hottinger AF; Modarressi A; Dietrich PY
    Anticancer Res; 2016 May; 36(5):2359-64. PubMed ID: 27127144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Squamous cell carcinoma, basal cell carcinoma].
    Ikeda S; Suzuki T; Kiyohara Y; Kuramochi A
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1293-301. PubMed ID: 7688499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapulmonary small cell carcinoma: a single-institution experience and review of the literature.
    Lo Re G; Canzonieri V; Veronesi A; Dal Bo V; Barzan L; Zancanaro C; Trovò M
    Ann Oncol; 1994 Dec; 5(10):909-13. PubMed ID: 7696162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
    Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
    Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution.
    Vokes EE; Mick R; Lester EP; Panje WR; Weichselbaum RR
    J Clin Oncol; 1991 Aug; 9(8):1376-84. PubMed ID: 2072141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients.
    Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L
    J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
    van Wijk FH; Aapro MS; Bolis G; Chevallier B; van der Burg ME; Poveda A; de Oliveira CF; Tumolo S; Scotto di Palumbo V; Piccart M; Franchi M; Zanaboni F; Lacave AJ; Fontanelli R; Favalli G; Zola P; Guastalla JP; Rosso R; Marth C; Nooij M; Presti M; Scarabelli C; Splinter TA; Ploch E; Beex LV; ten Bokkel Huinink W; Forni M; Melpignano M; Blake P; Kerbrat P; Mendiola C; Cervantes A; Goupil A; Harper PG; Madronal C; Namer M; Scarfone G; Stoot JE; Teodorovic I; Coens C; Vergote I; Vermorken JB;
    Ann Oncol; 2003 Mar; 14(3):441-8. PubMed ID: 12598351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study [corrected from prospective].
    Tsavaris N; Primikirios N; Mylonakis N; Varouchakis G; Dosios T; Pavlidis N; Skarlos D; Tasopoulos T; Dritsas J; Kosmidis P
    Anticancer Res; 1997; 17(5B):3799-802. PubMed ID: 9427783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin and 5-fluorouracil for metastatic squamous cell carcinoma from unknown primary.
    Khansur T; Allred C; Little D; Anand V
    Cancer Invest; 1995; 13(3):263-6. PubMed ID: 7743377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.